ALT5 Sigma (NASDAQ:AIFC) Trading 1.6% Higher – What’s Next?

ALT5 Sigma Corporation (NASDAQ:AIFC) shares were up 1.6% on Thursday . The company traded as high as $0.5632 and last traded at $0.5565. 336,280 shares changed hands during trading, a decline of 72% from the average session volume of 1,219,385 shares. The stock had previously closed at $0.5480.

Wall Street Analyst Weigh In

Separately, Wall Street Zen downgraded shares of ALT5 Sigma from a “sell” rating to a “strong sell” rating in a research note on Saturday, April 18th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

ALT5 Sigma Stock Up 1.6%

The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.03. The business has a fifty day moving average of $0.75 and a 200 day moving average of $1.21.

ALT5 Sigma (NASDAQ:AIFC) last posted its quarterly earnings data on Monday, May 18th. The company reported ($2.14) earnings per share (EPS) for the quarter. The business had revenue of $4.71 million for the quarter. ALT5 Sigma had a negative return on equity of 68.25% and a negative net margin of 2,483.94%.

Institutional Trading of ALT5 Sigma

Several institutional investors have recently added to or reduced their stakes in the stock. Private Advisor Group LLC boosted its stake in ALT5 Sigma by 138.0% during the 1st quarter. Private Advisor Group LLC now owns 94,857 shares of the company’s stock valued at $105,000 after acquiring an additional 55,000 shares during the last quarter. SG Americas Securities LLC increased its position in shares of ALT5 Sigma by 267.1% in the 1st quarter. SG Americas Securities LLC now owns 367,150 shares of the company’s stock worth $408,000 after purchasing an additional 267,150 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its stake in shares of ALT5 Sigma by 237.8% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 123,577 shares of the company’s stock valued at $136,000 after purchasing an additional 86,997 shares in the last quarter. Aristides Capital LLC acquired a new stake in shares of ALT5 Sigma in the 4th quarter valued at about $155,000. Finally, XTX Topco Ltd lifted its position in shares of ALT5 Sigma by 298.9% during the fourth quarter. XTX Topco Ltd now owns 489,500 shares of the company’s stock worth $538,000 after purchasing an additional 366,801 shares during the last quarter. 6.27% of the stock is owned by institutional investors and hedge funds.

About ALT5 Sigma

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties.